|
⚲
|
| Keyboard |
| Ho Carole
✚
|
|
|---|---|
| CIK # | 0001724605 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001724605] | |
| 4 | [0001724605] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Royalty Pharma PLC | |
| Ho Carole | |
| Lilly Eli & Co | |
| Denali Therapeutics Inc | |
| Beam Therapeutics Inc | |
| NGM Biopharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Denali Therapeutics Inc DNLI
Common Stock
|
2025-08-13 | Sell | 806 | $14.64 | 11,800 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2025-08-12 | Sell | 2,937 | $13.58 | 39,884 |
|
Denali Therapeutics Inc DNLI
Stock Option (right to buy) · derivative
|
2025-08-05 | Option exercise | 44,655 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2025-08-05 | Option exercise | 44,655 | $0.68 | 30,365 |
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2025-07-31 | Grant | 5,806 | $0.00 | |
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2025-07-31 | Grant | 2,752 | $0.00 | |
|
Beam Therapeutics Inc BEAM
Stock Option (Right to Buy) · derivative
|
2025-06-04 | Grant | 33,662 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2025-01-07 | Sell | 2,907 | $20.81 | 60,495 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2025-01-06 | Sell | 12,255 | $20.22 | 247,796 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2025-01-03 | Grant | 54,180 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Stock Option (right to buy) · derivative
|
2025-01-03 | Grant | 162,540 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2024-11-25 | Option exercise | 17,845 | $0.68 | 12,135 |
|
Denali Therapeutics Inc DNLI
Stock Option (right to buy) · derivative
|
2024-11-25 | Option exercise | 17,845 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2024-08-21 | Sell | 14,098 | $24.41 | 344,132 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2024-08-21 | Sell | 5,907 | $24.96 | 147,439 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2024-08-20 | Sell | 2,453 | $23.79 | 58,357 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2024-08-13 | Sell | 2,337 | $22.89 | 53,494 |
|
Beam Therapeutics Inc BEAM
Stock Option (Right to Buy) · derivative
|
2024-06-05 | Grant | 23,114 | $0.00 | |
|
NGM Biopharmaceuticals Inc NGM
Stock Option (Right to Buy) · derivative
|
2024-04-05 | Disposed to issuer | 78,407 | ||
|
NGM Biopharmaceuticals Inc NGM
Stock Option (Right to Buy) · derivative
|
2024-04-05 | Disposed to issuer | 24,222 | ||
| showing 20 of 191 most recent transactions | |||||